Influence of Valproic Acid on Extinction-based Therapy in Patients With Fear of Spiders.

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
Phobia, Specific
Interventions
DRUG

Valproic Acid

Once oral administration of 500mg before exposure therapy.

DRUG

Placebo

Once oral administration of 500mg before exposure therapy.

BEHAVIORAL

Fear reactivation

Fear reactivation before exposure therapy.

BEHAVIORAL

No fear reactivation

No fear reactivation before exposure therapy.

Trial Locations (1)

4012

Psychiatric University Clinics, University Basel, Basel

All Listed Sponsors
lead

Prof. Dominique de Quervain, MD

OTHER

NCT02789813 - Influence of Valproic Acid on Extinction-based Therapy in Patients With Fear of Spiders. | Biotech Hunter | Biotech Hunter